A dendritic cell (DC)-specific antibody to which an engineered Gag antigen is attached via a flexible linker. The gag antigen is less susceptible to proteolytic degradation by eliminating one or more proteolytic sites. The antibody is used for making vaccines and in methods to increase the effectiveness of antigen presentation by an antigen presenting cell.